Soluble receptors for tumor necrosis factor are markers for clinical course but not for major metabolic changes in human immunodeficiency virus infection

Metabolism. 1995 Dec;44(12):1564-9. doi: 10.1016/0026-0495(95)90076-4.

Abstract

Tumor necrosis factor alpha (TNF) is a potential mediator of the metabolic changes in human immunodeficiency virus type 1 (HIV) infection. Soluble TNF receptor types I and II (sTNFR-I and -II) presumably reflect TNF activity. To examine the relationship between s TNFRs and host metabolism, resting energy expenditure (REE), body composition, and transferrin, albumin, triglyceride, retinol-binding protein, and sTNFR concentrations were measured in 12 asymptomatic and 18 symptomatic HIV-infected male subjects and 15 male control subjects. sTNFRs were increased in parallel with disease severity. REE was elevated approximately 8% in HIV-infected subjects (P = .005). REE correlated positively with fat free mass (FFM) and the presence of HIV infection, but not with sTNFRs. Inverse correlations existed between sTNFR-I or -II and albumin concentration (r = -.48, P = .007, and r = -.49, P = .006, respectively), between sTNFR-II and transferrin concentration (r = -.53, P = .003), and between In(sTNFR-II) and percent body fat (r = -.37, P < .05), but not between sTNFRs and triglyceride or retinol-binding protein. Thus, sTNFRs are markers for clinical course but not for major metabolic changes in HIV infection.

Publication types

  • Comparative Study

MeSH terms

  • Adult
  • Biomarkers
  • Body Composition
  • Energy Metabolism
  • HIV Infections / blood*
  • Humans
  • Male
  • Middle Aged
  • Oxidation-Reduction
  • Receptors, Tumor Necrosis Factor / metabolism*
  • Reference Values
  • Solubility

Substances

  • Biomarkers
  • Receptors, Tumor Necrosis Factor